TickerFacts.

biote Corp. (BTMD): Operating Cash Flow

Annual figures by period end, from SEC filings.

$35.19M
Year ended 2025-12-31
$24.37M
Trailing 12 months to 2026-06-30
$45.24M2021-12-31: $33.72M2022-12-31: -$9.16M2023-12-31: $26.88M2024-12-31: $45.24M2025-12-31: $35.19M$35.19M
2021-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31$35.19M-22.2%2026-03-13, From 2025-01-01
2024-12-31$45.24M+68.3%2026-03-13, From 2024-01-01
2023-12-31$26.88Mn/m2025-03-14, From 2023-01-01
2022-12-31-$9.16Mn/m2024-03-15, From 2022-01-01
2021-12-31$33.72Mn/a2023-03-29, From 2021-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
biote Corp. (BTMD)2025-12-31$35.19M-22.2%
Glass House Brands Inc. (GLAS)2025-12-31$11.45M-59.7%
Marimed Inc. (MRMD)2025-12-31$7.70M+13.4%
Cronos Group Inc. (CRON)2025-12-31$25.87M+37.3%
Natural Alternatives International Inc (NAII)2026-06-30-$8.92Mn/m
Jushi Holdings Inc. (JUSH)2025-12-31$17.73M-17.8%
Niagen Bioscience, Inc. (NAGE)2025-12-31$13.50M+11.5%
Mannatech Inc (MTEX)2025-12-31-$2.96Mn/m
Fitlife Brands, Inc. (FTLF)2025-12-31$7.44M-22.6%

Compare BTMD, GLAS, MRMD, CRON side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗